CD36 Gene (Platelet Glycoprotein IV Deficiency) Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

🔬 Accuracy | 🚚 Logistics | 🩺 Clinical Guidance

Diagnostic Sensitivity 99.9% – ISO 9001:2015 accredited processing using NGS technology.
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
Telephonic Post-Test Guidance – Expert clinical interpretation by a DHA-licensed medical geneticist.
Direct Insurance Billing Verification – Contact via +971 54 548 8731 (WhatsApp available).

Test Overview & Methodology

The CD36 Gene NGS Test screens for pathogenic variants causing platelet glycoprotein IV deficiency, a hereditary bleeding disorder. This NGS‑based test analyzes the entire coding region and splice sites of the CD36 gene to identify mutations. It is ordered when patients present with unexplained mucocutaneous bleeding, thrombocytopenia, or a family history suggestive of a platelet disorder. The result helps confirm diagnosis, guide management, and inform genetic counseling for at‑risk relatives.

Feature	Our CD36 NGS Test	Closest Alternative
Precision	99.9% sensitivity; coverage of entire coding region & splice sites	Sanger sequencing – limited to known hotspots
Method	Next‑Generation Sequencing (NGS) – multi‑gene analysis possible	Single‑gene PCR + capillary electrophoresis
Turnaround Time	3–4 Weeks	4–6 Weeks (depending on lab)
Genetic Counseling	Mandatory pre‑test session with pedigree mapping (included)	Often not integrated; additional referrals needed

Physician Insight & Safety Protocols

“As a consultant medical geneticist, I understand the emotional weight of pursuing a genetic diagnosis for a bleeding disorder. This test provides definitive molecular confirmation, but it must always be correlated with your personal and family clinical story. My team and I are dedicated to delivering compassionate, evidence‑based guidance every step of the way.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403

Important Medication Advisory

⚠ Important Medication Warning

Do not discontinue any prescribed medication, especially antiplatelets or anticoagulants, without explicit consultation with your treating physician. This genetic test does not provide immediate therapeutic guidance.

Safety Exclusion Criteria & Emergency Red Flags

Safety Exclusion Criteria

Specimen collection is not performed on individuals with active, untreated bleeding diathesis unless cleared by a physician.
Patients on high‑dose anticoagulants must disclose their regimen; home phlebotomy may still proceed with caution.
Genetic testing of minors requires parental consent as per UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
ER Red Flags: If you experience prolonged bleeding (>15 min), large hematoma, dizziness, or signs of infection at the draw site after blood collection, seek immediate medical attention.

Patient FAQ & Clinical Guidance

1. What is the CD36 gene test and why is it performed?

This NGS‑based test analyzes the entire CD36 gene to detect mutations causing glycoprotein IV deficiency, a bleeding disorder. It is ordered when a patient presents with unexplained mucocutaneous bleeding, thrombocytopenia, or a family history suggestive of a platelet disorder. The result helps confirm the diagnosis, guide management, and inform genetic counseling for at‑risk relatives.

2. How should patients prepare for the CD36 genetic test?

A pre‑genetic counseling session and pedigree charting are mandatory to ensure accurate interpretation and informed consent. During this visit, the clinician reviews your bleeding history, medication list, and constructs a family tree. The sample itself requires no fasting; a small amount of blood (EDTA tube) or a dried blood spot on an FTA card is collected by a certified phlebotomist.

3. How long does it take to receive results?

The turnaround time for the CD36 NGS test is 3–4 weeks from sample receipt. This includes sequencing, bioinformatics analysis, variant interpretation, and the preparation of a comprehensive report. You will be notified once the report is ready, and a follow‑up genetic counseling session can be scheduled at your convenience.

UAE Regulatory & Data Privacy Adherence

Data Privacy & Compliance

DNA Labs UAE adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and securely stored. Patient consent is obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA facility license number is 1143.

Clinical & Logistical Metadata

Test Name	CD36 Gene (Platelet Glycoprotein IV Deficiency) Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)
Methodology Used	Next-Generation Sequencing (NGS)
ICD-10-CM Code	D69.1 (Qualitative platelet defects)
LOINC Code	81247-9 (CD36 gene mutation analysis)
DHA Facility License & Laboratory Address	DHA License 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE